WHO signs MoU with International Generic and Biosimilar Medicines Association to promote access

Health Policy Watch: Forum Discusses High Drug Prices in… 12 February 2024 Adrian van den Hoven, chair of the International Generic and…
Access to medicines and security of supply should be central… 13 June 2023 Generic and biosimilar medicines significantly lower healthcare treatment costs and…
Final recommendations from "Ensuring equitable and… 17 November 2022 Medicines for Europe, the European off-patent medicines association, and CAFF,…
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…